Novartis Reports Q1 Profit up on Divestitures - The New Indian Express

Novartis Reports Q1 Profit up on Divestitures

Published: 24th April 2014 11:42 AM

Last Updated: 24th April 2014 11:45 AM

Swiss pharmaceutical company Novartis AG has reported a 24 percent increase in profit for the first quarter, helped by selling off less-profitable parts of its business.

The Basel, Switzerland-based company says its net profit rose to nearly $2.97 billion, up from $2.42 billion in the period last year, driven by strong sales, key drug approvals and other factors such as growth in emerging markets, particularly China.

In a statement Thursday, the company attributed its quarterly profit to "higher operating income driven by the exceptional divestment gain and higher income from associated companies."

On Tuesday, Novartis launched a major overhaul of its business through a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and Eli Lilly & Co. of the United States.

comments powered by Disqus

Disclaimer: We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the NIE editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.


Read More



follow us Mobile Site iPad News Hunt Android RSS Tumblr Linekin Pinterest Youtube Google Plus Twitter Facebook